Peptide library
LL-37
Your guide to this compound.
Dose context
Study context only; no personal treatment regimen.
The venous-ulcer trial evaluated topical solutions at 0.5 or 1.6 mg/mL with compression. Concentration is not an injected dose; this does not establish a subcutaneous regimen.
How to read this information
Catalog ranges can describe approved labeling, clinical research or unverified reports. They are not interchangeable and do not select a personal dose.
Half-life
A formulation-, route- and population-specific human half-life was not established in this source review.
Species, route and formulation matter. Half-life does not define a safe dosing interval.
Routes and frequency in the catalog
No validated route or schedule recorded.
Storage
No product-specific storage or post-preparation stability instructions were verified. A shelf life cannot be inferred from the peptide name alone.
Generic storage notes cannot establish a beyond-use date or sterility for a particular vial.
Preparation and reconstitution
No preparation instructions for a verified human-use product were established in this review.